ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VRAX Virax Biolabs Group Ltd

0.717
0.012 (1.70%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Virax Biolabs Group Ltd VRAX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.012 1.70% 0.717 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.706 0.705 0.78 0.717 0.705
more quote information »

Recent News

Date Time Source Heading
3/15/202416:30PRNUSVirax Biolabs Announces Receipt of NASDAQ Notification..
1/22/202417:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/22/202417:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/12/202407:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202307:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202307:30PRNUSVirax Biolabs Forges Strategic Research Collaboration with..
12/20/202316:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/20/202316:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202316:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/18/202307:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/18/202307:30PRNUSVirax Biolabs' CEO James Foster Issues Letter to..
12/18/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
12/14/202307:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/202307:30PRNUSVirax Biolabs Group Limited Announces 1-for-10 Share..
12/08/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/202316:06EDGAR2Form F-3 - Registration statement by foreign private issuers
11/08/202316:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202316:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202307:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202307:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202307:30PRNUSVirax Biolabs Group Announces Early-Access Program Launch of..
9/01/202307:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/202307:30PRNUSVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief..
8/03/202308:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/03/202307:30PRNUSNasdaq Approves 180-Day Extension for Virax Biolabs Group to..
7/18/202307:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/18/202307:30PRNUSVirax Biolabs Group Continues Growth and Expansion with the..
6/14/202307:30PRNUSVirax Biolabs' CEO James Foster Issues Letter to..
5/04/202307:30PRNUSVirax Biolabs Group Announces Establishment of Regional..
4/19/202307:30PRNUSVirax Biolabs Group Limited Has Entered into an Agreement..

Your Recent History

Delayed Upgrade Clock